Form SCHEDULE 13D/A Alaunos Therapeutics, Filed by: Price Adrian
Tweet
Share
E-mail|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
|
Alaunos Therapeutics, Inc. (Name of Issuer) |
Common stock (Title of Class of Securities) |
98973P309 (CUSIP Number) |
Samuel E. Whitley 24285 Katy Freeway, Suite 300, Katy, TX, 77494 2812060434 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
02/24/2026 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Price Adrian | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
189,061.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
8.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Chris Butterworth | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,700.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Richard Jones | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
16,000.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.7 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Edward Jones | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
11,750.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Gareth Downing | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
19,552.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.9 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Richard Kotey | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
12,530.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Chris Cole | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
15,856.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.7 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Arif Chaudrey | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
6,423.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.3 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Emma Babb | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,366.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Colin Craig | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
7,000.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.3 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
John Nicholls | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
16,743.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.8 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Carl Ware | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
1,721.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.1 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Andrew Turner | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
13,035.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Matthew Robbins | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,036.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Phillip James Stead | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
11,012.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Stephen Hennessy | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
7,108.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.3 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Greg Arnold | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,735.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Michelle Douglas | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
8,494.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
HexagonONE Ltd | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
VIRGIN ISLANDS, BRITISH
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Alimenta Holding Limited | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
VIRGIN ISLANDS, BRITISH
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Krakatau Holding Limited | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
VIRGIN ISLANDS, BRITISH
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
0.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common stock | |
| (b) | Name of Issuer:
Alaunos Therapeutics, Inc. | |
| (c) | Address of Issuer's Principal Executive Offices:
501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE,
TEXAS
, 33301. | |
Item 1 Comment:
This Amendment No. 4 is being filed to correct the names of the Reporting Persons reported in Amendment No. 3 (the "New Reporting Persons"), add the addresses of the New Reporting Persons, attach powers of attorney for the New Reporting Persons, and attach a Joint Filing Agreement for the Reporting Persons. | ||
| Item 2. | Identity and Background | |
| (a) | The below persons are collectively referred to herein as the Reporting Persons. Each of the Reporting Persons files this Schedule 13D jointly. The Reporting Persons are filing this Schedule 13D jointly, as they may be considered a Group under Section 13(d)(3) of the Act. However, neither the fact of this filing nor anything contained herein shall be deemed to be an admission by the Reporting Persons that such a group exists.
Chris Butterworth
Richard Jones
Edward Jones
Gareth Downing
Richard Kotey
Chris Cole
Arif Chaudrey
Emma Babb
Colin Craig
John Nicholls
Carl Ware
Andrew Turner
Matthew Robbins
Phillip James Stead
Stephen Hennessy
Greg Arnold
Michelle Douglas
HexagonONE Ltd
Krakatau Holding Limited
Alimenta Holding Limited | |
| (b) |
Chris Butterworth: 12A Grahamshill Street, Airdrie, ML6 7EN, United Kingdom
Richard Jones: 28 Jedburgh Street, Blantyre, Glasgow, South Lanarkshire, G72 0SU, United Kingdom
Edward Jones: 21 Langdale Avenue, Formby, Liverpool, L37 2LB, United Kingdom
Gareth Downing: 14 Osier Way, Banstead, SM7 1LL, United Kingdom
Richard Kotey: 13 Mendez Way, London, SW15 5GA, United Kingdom
Chris Cole: 18 Herons Way, Hayling Islang, Hants, PO11 9FL, United Kingdom
Arif Chaudrey: 25 Bays Crescent, Spencers Wood, Reading, RG7 1DF, United Kingdom
Emma Babb: 71 Stanborrough Avenue, Borhamwood, Harts, WD6 5LX, United Kingdom
Colin Craig: 43 Inverary Drive, Belfast, BT4 1RD, United Kingdom
John Nicholls: 41 Lea Castle Drice, Lea Castle, Kiddermister, Worcs, DY10 3FB, United Kingdom
Carl Ware: 20 Roveley Court, Stony Stratford, Milton Keynes, MK11 1NU, United Kingdom
Andrew Turner: 26 Sun Vale Avenue, Todmorden, West Yorkshire, OL14 6TP, United Kingdom
Matthew Robbins: 42 Tattersall Road, Yate, Bristol, BS37 7GW, United Kingdom
Phillip James Stead: 113 Dartmouth Avenue, Wallsal, West Midlands, WS3 1SP, United Kingdom
Stephen Hennessy: 57 Regent House, Station Road, Strood, Kent, ME2 4WQ, United Kingdom
Greg Arnold: 1 Hickling Close, Long Eaton, Nottingham, NG10 3TE, United Kingdom
Michelle Douglas: 13 Mendez Way, London, SW15 5GA, United Kingdom
HexagonONE Ltd: Oleander Building, Suites OL-7 & OL-8, 13A J.R. O'Neal Drive, Port Purcell, Tortola, British Virgin Islands
Krakatau Holding Limited: Keyway Chambers, 3rd Floor, Quastisky Building, Road Town, Tortola, British Virgin Islands
Alimenta Holding Limited: Keyway Chambers, 3rd Floor, Quastisky Building, Road Town, Tortola, British Virgin Islands | |
| (c) | Chris Butterworth: self-employed electrician;12A Grahamshill Street, Airdrie, ML6 7EN, United Kingdom
Richard Jones: manager at Balfour Beatty; Huntly Road, Glasgow, G52 4DZ, United Kingdom
Edward Jones: self-employed software developer; 21 Langdale Avenue, Formby, Liverpool, L37 2LB, United Kingdom
Gareth Downing: ops manager at M Group; Gunnells Eood Rd, Stevenage, United Kingdom
Richard Kotey: tutor at United Colleges Group; 26 Paddington Green, W2 1NB, United Kingdom
Chris Cole: self-employed carpenter; 18 Herons Way, Hayling Islang, Hants, PO11 9FL, United Kingdom
Arif Chaudrey: petroleum engineer at KBR Consulting; KT22 7NL, Letterhead, United Kingdom
Emma Babb: housewife; 71 Stanborrough Avenue, Borhamwood, Harts, WD6 5LX, United Kingdom
Colin Craig: support worker/subcontractor at various companies; 43 Inverary Drive, Belfast, BT4 1RD, United Kingdom
John Nicholls: field service engineer at Clearmark Solutions; Olympic House, Nottingham, NG15 0DP, United Kingdom
Carl Ware: self-employed IT consultant; 20 Roveley Court, Stony Stratford, Milton Keynes, MK11 1NU, United Kingdom
Andrew Turner: ops manager at Urbasers; 3 Sidings Court, Doncaster DN4 5NU, United Kingdom
Matthew Robbins: student at Bristol University; Beacon House Bristol, BS8 1QU, United Kingdom
Phillip James Stead: events manager at Walsal FC; Beacon House Bristol, BS8 1QU, United Kingdom
Stephen Hennessy: engineer at Go Fix; Beechcroft Farm ind estate, TN15 7HX, United Kingdom
Greg Arnold: project supervisor at CITY; Caldonia House Glasgow, United Kingdom
Michelle Douglas: manager at NHS; PO Box 130, Morden, SM4 9EF, United Kingdom
HexagonONE Ltd: unknown
Krakatau Holding Limited: unknown
Alimenta Holding Limited: unknown | |
| (d) | Chris Butterworth: No
Richard Jones: No
Edward Jones: No
Gareth Downing: No
Richard Kotey: No
Chris Cole: No
Arif Chaudrey: No
Emma Babb: No
Colin Craig: No
John Nicholls: No
Carl Ware: No
Andrew Turner: No
Matthew Robbins: No
Phillip James Stead: No
Stephen Hennessy: No
Greg Arnold: No
Michelle Douglas: No
HexagonONE Ltd: No
Krakatau Holding Limited: No
Alimenta Holding Limited: No | |
| (e) | Chris Butterworth: No
Richard Jones: No
Edward Jones: No
Gareth Downing: No
Richard Kotey: No
Chris Cole: No
Arif Chaudrey: No
Emma Babb: No
Colin Craig: No
John Nicholls: No
Carl Ware: No
Andrew Turner: No
Matthew Robbins: No
Phillip James Stead: No
Stephen Hennessy: No
Greg Arnold: No
Michelle Douglas: No
HexagonONE Ltd: No
Krakatau Holding Limited: No
Alimenta Holding Limited: No | |
| (f) | Chris Butterworth: United Kingdom
Richard Jones: United Kingdom
Edward Jones: United Kingdom
Gareth Downing: United Kingdom
Richard Kotey: United Kingdom
Chris Cole: United Kingdom
Arif Chaudrey: United Kingdom
Emma Babb: United Kingdom
Colin Craig: United Kingdom
John Nicholls: United Kingdom
Carl Ware: United Kingdom
Andrew Turner: United Kingdom
Matthew Robbins: United Kingdom
Phillip James Stead: United Kingdom
Stephen Hennessy: United Kingdom
Greg Arnold: United Kingdom
Michelle Douglas: United Kingdom
HexagonONE Ltd: British Virgin Islands
Krakatau Holding Limited: British Virgin Islands
Alimenta Holding Limited: British Virgin Islands | |
| Item 3. | Source and Amount of Funds or Other Consideration | |
Chris Butterworth: personal funds
Richard Jones: personal funds
Edward Jones: personal funds
Gareth Downing: personal funds
Richard Kotey: personal funds
Chris Cole: personal funds
Arif Chaudrey: personal funds
Emma Babb: personal funds
Colin Craig: personal funds
John Nicholls: personal funds
Carl Ware: personal funds
Andrew Turner: personal funds
Matthew Robbins: personal funds
Phillip James Stead: personal funds
Stephen Hennessy: personal funds
Greg Arnold: personal funds
Michelle Douglas: personal funds
HexagonONE Ltd: working capital
Krakatau Holding Limited: working capital
Alimenta Holding Limited: working capital | ||
| Item 4. | Purpose of Transaction | |
On February 24, 2026, counsel for Adrian Price sent a letter on behalf of the Reporting Persons to counsel of Alaunos Therapeutics, Inc. (the "Company"), and requested that the Company's counsel provide the letter to the Company's Board of Directors ("Board").
In this letter, Mr. Price proposed a private placement whereby HexagonONE Ltd, Alimenta Holding Limited and Krakatau Holding Limited (the "Investors") would purchase $7,000,000 of securities of the Company subject to mutually agreeable definitive documentation and customary closing conditions. The securities purchased by the Investors would be equity or equity-linked securities, with the purchase price to be negotiated in good faith, taking into account market conditions, the Company's liquidity needs, and long-term shareholder alignment. The Investors proposed that the private placement close as soon as practicable following Board approval and completion of documentation and shareholder approval (if required by Nasdaq rules).
The letter requested the Board meet with Mr. Price within five business days to begin term sheet negotiation and due diligence.
The letter also reiterated the Reporting Persons' nomination of Gerald Bruce to the Board and requested that the Board appoint Mr. Bruce as a director.
The letter stated that if the Board did not engage meaningfully with Mr. Price within this five business day period, then the Reporting Persons may seek to purchase additional shares of the Company in the market or undertake a tender offer to shareholders. The letter also mentioned that the Reporting Persons could undertake an investor relations campaign if the Board did not engage meaningfully with Mr. Price.
In the letter, Mr. Price reserved all rights belonging to the Reporting Persons as shareholders of the Company.
If consummated, it its anticipated that the proposed private placement would result in a change of control of the Company.
The letter sent by Mr. Price is attached hereto as Exhibit 21. This letter was sent as part of the Reporting Persons' efforts to help create shareholder value, and the Reporting Persons intend to continue these efforts.
The Reporting Persons may purchase and sell common stock of the Company in their sole discretion and at such times as they deem convenient, subject to applicable law.
Other than as set forth above, the Reporting Persons do not intend to take any other actions described in subsections (a) through (j) of Item 4 of Schedule 13D at this time; however, they reserve the right to do so. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | The information contained in Rows 7, 8, 9, 10, 11, and 13 of each Reporting Person's cover page to this Schedule 13D (including the footnotes thereto), and in Items 2 and 3 of this amendment, are incorporated by reference into this Item 5. Adrian Price disclaims beneficial ownership of the securities discussed herein. | |
| (b) | The information contained in Rows 7, 8, 9, 10, 11, and 13 of each Reporting Person's cover page to this Schedule 13D (including the footnotes thereto), and in Items 2 and 3 of this amendment, are incorporated by reference into this Item 5. Adrian Price disclaims beneficial ownership of the securities discussed herein. | |
| (c) | The Reporting Persons have not conducted any transactions in Alaunos securities in the past 60 days. | |
| (d) | N/A | |
| (e) | N/A | |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer | |
The Reporting Persons have entered into a Joint Filing Agreement, which is set forth hereto as Exhibit 1 and incorporated by reference, and Exhibit 22.
The Reporting Persons have granted Adrian Price a power of attorney to sign and file this Schedule 13D (and any amendments) and the Joint Filing Agreement with the Securities and Exchange Commission. These powers of attorney are set forth as Exhibits 23-25.
Other than as described herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of Alaunos. | ||
| Item 7. | Material to be Filed as Exhibits. | |
Exhibit 1 Joint Filing Agreement, incorporated by reference
Exhibit 2 Power of Attorney: Chris Butterworth, incorporated by reference
Exhibit 3 Power of Attorney: Richard Jones, incorporated by reference
Exhibit 4 Power of Attorney: Edward Jones, incorporated by reference
Exhibit 5 Power of Attorney: Gareth Downing, incorporated by reference
Exhibit 7 Power of Attorney: Richard Kotey, incorporated by reference
Exhibit 8 Power of Attorney: Chris Cole, incorporated by reference
Exhibit 9 Power of Attorney: Arif Chaudrey, incorporated by reference
Exhibit 10 Power of Attorney: Emma Babb, incorporated by reference
Exhibit 11 Power of Attorney: Colin Craig, incorporated by reference
Exhibit 12 Power of Attorney: John Nicholls, incorporated by reference
Exhibit 13 Power of Attorney: Carl Ware, incorporated by reference
Exhibit 14 Power of Attorney: Andrew Turner, incorporated by reference
Exhibit 15 Power of Attorney: Matthew Robbins, incorporated by reference
Exhibit 16 Power of Attorney: Phillip James Stead, incorporated by reference
Exhibit 17 Power of Attorney: Stephen Hennessy, incorporated by reference
Exhibit 18 Power of Attorney: Greg Arnold, incorporated by reference
Exhibit 19 Power of Attorney: Michelle Douglas, incorporated by reference
Exhibit 20 Letter to Alaunos Board of Directors, incorporated by reference
Exhibit 21 Proposal to the Board of Directors of Alaunos Therapeutics (TCRT), incorporated
by reference
Exhibit 22 Joint Filing Agreement for HexagonONE Ltd, Krakatau Holding Limited, and
Alimenta Holding Limited
Exhibit 23 Power of Attorney: HexagonONE Ltd
Exhibit 24 Power of Attorney: Krakatau Holding Limited
Exhibit 25 Power of Attorney: Alimenta Holding Limited | ||
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ATTACHMENTS / EXHIBITS
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
13DSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
